Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Devlin

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 26, 2019
Pilot Study of Bortezomib and Dexamethasone Pre- and Post-Risk-Adapted Autologous Stem Cell Transplantation in AL AmyloidosisHeather Landau, Oscar Lahoud, Sean Devlin, et al.
Leukemia & Lymphoma|January 21, 2020
A phase II clinical trial of lenalidomide intensification in patients with serologic/asymptomatic progression of multiple myeloma while on lenalidomide maintenance: a tri-state transplant consortium studyHani Hassoun, Ruthee Bayer, Sean Devlin, et al.
Bone Marrow Transplantation|July 8, 2023
Application of the CIBMTR One Year Survival Outcomes Calculator as a tool for retrospective analysisChristina Cho, Sean Devlin, Molly Maloy, et al.
British Journal of Haematology|June 29, 2016
Treatment outcomes and secondary cancer incidence in young patients with hairy cell leukaemiaBartlomiej M Getta, Kaitlin M Woo, Sean Devlin, et al.
Bone Marrow Transplantation|October 4, 2025
Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host diseaseGagan Raju, Moneeza Walji, David Nemirovsky, et al.
Bone Marrow Transplantation|March 30, 2026
Correction: Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host diseaseGagan Raju, Moneeza Walji, David Nemirovsky, et al.
JACC. Cardiooncology|May 5, 2023
Tumor Genomic Profile Is Associated With Arterial Thromboembolism Risk in Patients With Solid CancerStephanie Feldman, Dipti Gupta, Babak B Navi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 19, 2018
Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantationClaudia Rosillo, Ana Maria Avila, Yao-Ting Huang, et al.
Hemasphere|February 9, 2022
Reduced Plasmacytoid Dendritic Cell Output Is Associated With High Risk in Low-grade Myelodysplastic SyndromeAlexander Chan, Ying Liu, Sean Devlin, et al.
Blood Advances|November 29, 2023
Gender disparities in allograft access due to HLA-sensitization in multiparous womenWarren B Fingrut, Eric Davis, Anne Archer, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 26, 2019
Pilot Study of Bortezomib and Dexamethasone Pre- and Post-Risk-Adapted Autologous Stem Cell Transplantation in AL AmyloidosisHeather Landau, Oscar Lahoud, Sean Devlin, et al.
Leukemia & Lymphoma|January 21, 2020
A phase II clinical trial of lenalidomide intensification in patients with serologic/asymptomatic progression of multiple myeloma while on lenalidomide maintenance: a tri-state transplant consortium studyHani Hassoun, Ruthee Bayer, Sean Devlin, et al.
Bone Marrow Transplantation|July 8, 2023
Application of the CIBMTR One Year Survival Outcomes Calculator as a tool for retrospective analysisChristina Cho, Sean Devlin, Molly Maloy, et al.
British Journal of Haematology|June 29, 2016
Treatment outcomes and secondary cancer incidence in young patients with hairy cell leukaemiaBartlomiej M Getta, Kaitlin M Woo, Sean Devlin, et al.
Bone Marrow Transplantation|October 4, 2025
Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host diseaseGagan Raju, Moneeza Walji, David Nemirovsky, et al.
Bone Marrow Transplantation|March 30, 2026
Correction: Real-world experience of belumosudil and belumosudil/ruxolitinib combination in steroid-refractory chronic graft-versus-host diseaseGagan Raju, Moneeza Walji, David Nemirovsky, et al.
JACC. Cardiooncology|May 5, 2023
Tumor Genomic Profile Is Associated With Arterial Thromboembolism Risk in Patients With Solid CancerStephanie Feldman, Dipti Gupta, Babak B Navi, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 19, 2018
Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantationClaudia Rosillo, Ana Maria Avila, Yao-Ting Huang, et al.
Hemasphere|February 9, 2022
Reduced Plasmacytoid Dendritic Cell Output Is Associated With High Risk in Low-grade Myelodysplastic SyndromeAlexander Chan, Ying Liu, Sean Devlin, et al.
Blood Advances|November 29, 2023
Gender disparities in allograft access due to HLA-sensitization in multiparous womenWarren B Fingrut, Eric Davis, Anne Archer, et al.
Pageof 8